Literature DB >> 19685266

Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study.

Frans J Th Wackers, Lawrence H Young.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19685266     DOI： 10.1007/s12350-009-9138-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  19 in total

1.  Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group.

Authors: 
Journal:  Am J Cardiol       Date:  1997-01-15       Impact factor: 2.778

2.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus.

Authors:  X Kang; D S Berman; H C Lewin; I Cohen; J D Friedman; G Germano; R Hachamovitch; L J Shaw
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

3.  Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.

Authors:  Andrea De Lorenzo; Ronaldo S L Lima; Aristarco G Siqueira-Filho; Mauricio R Pantoja
Journal:  Am J Cardiol       Date:  2002-10-15       Impact factor: 2.778

4.  Silent myocardial ischemia in patients with diabetes: who to screen.

Authors:  B Janand-Delenne; B Savin; G Habib; M Bory; P Vague; V Lassmann-Vague
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing.

Authors:  A Penfornis; C Zimmermann; D Boumal; A Sabbah; N Meneveau; S Gaultier-Bourgeois; J P Bassand; Y Bernard
Journal:  Diabet Med       Date:  2001-11       Impact factor: 4.359

6.  Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism.

Authors:  Carmine Gazzaruso; Adriana Garzaniti; Stefano Giordanetti; Colomba Falcone; Emanuela De Amici; Diego Geroldi; Pietro Fratino
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

7.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

8.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

Authors:  Lawrence H Young; Frans J Th Wackers; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Gary V Heller; Ami E Iskandrian; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

9.  Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.

Authors:  Frans J Th Wackers; Deborah A Chyun; Lawrence H Young; Gary V Heller; Ami E Iskandrian; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  Diabetes Care       Date:  2007-08-06       Impact factor: 19.112

10.  Prognostic value of dobutamine-atropine stress myocardial perfusion imaging in patients with diabetes.

Authors:  Arend F L Schinkel; Abdou Elhendy; Ron T van Domburg; Jeroen J Bax; Eleni C Vourvouri; Fabiola B Sozzi; Roelf Valkema; Jos R T C Roelandt; Don Poldermans
Journal:  Diabetes Care       Date:  2002-09       Impact factor: 19.112
View more
  5 in total

1.  The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.

Authors:  Robert C Hendel; Brian G Abbott; Timothy M Bateman; Ron Blankstein; Dennis A Calnon; Jeffrey A Leppo; Jamshid Maddahi; Matthew M Schumaecker; Leslee J Shaw; R Parker Ward; David G Wolinsky
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

2.  Screening asymptomatic patients with type 2 diabetes is recommended: Pro.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2015-09-21       Impact factor: 5.952

3.  [Diabetes, prediabetes and cardiovascular risk].

Authors:  B Stratmann; D Tschoepe
Journal:  Internist (Berl)       Date:  2015-06       Impact factor: 0.743

4.  Refining risk in diabetes and CAD with SPECT MPI: New insights and future challenges.

Authors:  Syed Y Naqvi; Steven D Wittlin; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2018-02-05       Impact factor: 5.952

5.  Cardiac risk assessment in asymptomatic diabetes: combining [corrected] different imaging modalities and surrogate markers?

Authors:  Arthur J H A Scholte
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.